Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform
BRUSSELS, BELGIUM, September 9, 2021 /EINPresswire.com/ -- Newton Biocapital (“Newton”), a life sciences investment fund active in Europe and Japan and focused on the treatment and prevention of chronic diseases, has announced its new investment in PRISM …